Physician profile
Wayne Kelley
NPI 1205002748
$180,031.36
in general payments reported to CMS, 2019-2025
37 companies · $7,977 in 2025
The $7,977 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $39K · 2021: $38K · 2022: $23K · 2023: $7,807 · 2024: $4,317 · 2025: $7,977.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,433 · Food and Beverage: $6,454 · Consulting Fee: $5,200 · Education: $13.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,433.48 |
| Food and Beverage | $6,453.75 |
| Consulting Fee | $5,200.00 |
| Education | $13.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osseus Fusion Systems, LLC | $80,846.47 | 2019-2021 | |
| Aegis Spine, INC. | $16,133.00 | 2022 | |
| Choice Spine, LLC | $14,248.57 | 2019-2025 | Thunderbolt Minimally Invasive Pedicle Screw Systems, Stratofuse, Blackhawk Cervical Spacer System |
| Seaspine Orthopedics Corporation | $13,820.24 | 2019-2021 | |
| Curiteva, INC. | $10,198.63 | 2020-2025 | |
| Cerapedics INC. | $8,517.08 | 2021-2025 | I-Factor Peptide Enhanced Bone Graft |
| Spinal Simplicity, LLC | $8,031.91 | 2021-2023 | Ha Minuteman G3-R |
| Depuy Synthes Products, INC. | $5,614.23 | 2019 | |
| Boston Scientific Corporation | $5,560.88 | 2019-2025 | Superion Indirect Decompression System, General - Pain Management, Wavewriter Alpha Prime 16 |
| Alphatec Spine, INC | $4,308.02 | 2024-2025 | Other - Miscellaneous, Identiti, Invictus Mis |
| Elevation Spine, INC. | $2,500.00 | 2023-2024 | |
| Globus Medical, INC. | $2,093.62 | 2025 | Creo, Tlif |
| Republic Spine | $2,017.66 | 2020-2021 | |
| Amgen INC. | $1,523.35 | 2019-2024 | |
| Avanos Medical | $723.53 | 2021-2023 | On-Q* Pump and Accessories |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $545.04 | 2021-2022 | |
| Medtronic, INC. | $402.34 | 2021-2025 | Unid_pass, Kyphon Express II Kyphopak Tray, Mazor X System |
| Medtronic USA, INC. | $368.33 | 2019-2020 | |
| Si-Bone, INC. | $295.72 | 2019-2025 | |
| Depuy Synthes Sales INC. | $282.95 | 2019-2020 | |
| Baxter Healthcare | $209.23 | 2019-2021 | |
| Biodelivery Sciences International, INC. | $159.22 | 2019-2020 | |
| Prosidyan, INC | $158.84 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $143.92 | 2025 | Caldolor |
| Smith+Nephew, INC. | $130.66 | 2019-2020 | |
| Radius Health, INC. | $123.85 | 2025 | Tymlos |
| Stryker Corporation | $123.41 | 2023 | Spinemap |
| Nevro Corp. | $122.75 | 2021 | |
| Next Science LLC | $118.00 | 2020 | |
| Spr Therapeutics, INC | $117.06 | 2025 | Sprint Pns System |
| Intrinsic Therapeutics | $114.72 | 2025 | Barricaid Acd (Annular Closure Device) |
| 7d Surgical Ulc | $112.80 | 2021 | |
| Surgalign Spine Technologies, INC. | $99.70 | 2021 | |
| Nalu Medical, INC. | $95.13 | 2022 | |
| Captiva Spine INC | $90.65 | 2021 | |
| Adcura, INC. | $65.95 | 2023 | |
| Elutia, INC. | $13.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,844,205.40 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.